<DOC>
	<DOCNO>NCT01373814</DOCNO>
	<brief_summary>The goal study determine nutritional therapy effectively treat/prevent T2DM consequent cardiomyopathy .</brief_summary>
	<brief_title>Nutritional Therapy Diabetic Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Diabetic Cardiomyopathies</mesh_term>
	<criteria>Subjects must &gt; 30 &lt; 65 year age , order limit confound affect age endpoint . Subjects must ejection fraction &gt; 45 % ( base echocardiogram ) Patients T2DM nonalcoholic fatty liver disease steatohepatitis may include since extensive evidence steatosis . Subjects myocardial infarction rest ischemia ( history evidence hypo/akinesis preintervention echocardiogram ) exclude hypo/akinesis would affect endpoint LV mass diastolic function . Subjects unstable , able lie flat imaging study , unable give inform consent , pregnant , lactating , atrial fibrillation ( would compromise measurement E ' ) , current smoker exclude . Subjects major systemic disease per clinical chart , history , physical exam , significant renal insufficiency also exclude , system disease may affect study endpoint subject followup . We exclude patient significant LV systolic dysfunction ( ejection fraction &lt; 45 % ) We exclude patient sleep apnea detrimentally affect LV diastolic function . Subjects exclude priori history evidence liver disease NAFLD , consume &gt; 20 g alcohol per day .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>